CSBR
CHAMPIONS ONCOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$5.15
+1.28%Leverage
- Debt / equity
- 2.82x
- Net debt / equity
- 1.70x
- Debt / assets
- 0.33x
- Debt / EBITDA
- 24.54x
- Net debt / EBITDA
- 14.79x
Liquidity & coverage
- Current ratio
- 1.03x
- Quick ratio
- 1.03x
- Cash ratio
- 0.23x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $563.0K
Cash & dividend
- FCF / debt
- -0.56x
- Cash flow / debt
- -0.51x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jul 1, 2026